These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33047134)

  • 1. Sensorimotor and Activity Psychosis-Risk (SMAP-R) Scale: An Exploration of Scale Structure With Replication and Validation.
    Damme KSF; Schiffman J; Ellman LM; Mittal VA
    Schizophr Bull; 2021 Mar; 47(2):332-343. PubMed ID: 33047134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological Signs at the First Psychotic Episode as Correlates of Long-Term Outcome: Results From the AESOP-10 Study.
    Ferruccio NP; Tosato S; Lappin JM; Heslin M; Donoghue K; Giordano A; Lomas B; Reininghaus U; Onyejiaka A; Chan RCK; Croudace T; Jones PB; Murray RM; Fearon P; Doody GA; Morgan C; Dazzan P
    Schizophr Bull; 2021 Jan; 47(1):118-127. PubMed ID: 32656567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Social Functioning Scale modified for use in individuals at clinical high-risk for psychosis.
    Kuhney FS; Damme KSF; Ellman LM; Schiffman J; Mittal VA
    Schizophr Res; 2022 Oct; 248():246-253. PubMed ID: 36115189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting motor slowing in clinical high risk for psychosis in a computerized finger tapping model.
    Damme KSF; Osborne KJ; Gold JM; Mittal VA
    Eur Arch Psychiatry Clin Neurosci; 2020 Apr; 270(3):393-397. PubMed ID: 31432263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three prominent self-report risk measures show unique and overlapping utility in characterizing those at clinical high-risk for psychosis.
    Williams TF; Powers AR; Ellman LM; Corlett PR; Strauss GP; Schiffman J; Waltz JA; Silverstein SM; Woods SW; Walker EF; Gold JM; Mittal VA
    Schizophr Res; 2022 Jun; 244():58-65. PubMed ID: 35597134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal movements in first-episode, nonaffective psychosis: dyskinesias, stereotypies, and catatonic-like signs.
    Compton MT; Fantes F; Wan CR; Johnson S; Walker EF
    Psychiatry Res; 2015 Mar; 226(1):192-7. PubMed ID: 25619434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Movement abnormalities predict transitioning to psychosis in individuals at clinical high risk for psychosis.
    Callaway DA; Perkins DO; Woods SW; Liu L; Addington J
    Schizophr Res; 2014 Nov; 159(2-3):263-6. PubMed ID: 25311779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Computerized Adaptive Assessment Tool for Discrimination and Measurement of Psychotic Symptoms.
    Guinart D; de Filippis R; Rosson S; Patil B; Prizgint L; Talasazan N; Meltzer H; Kane JM; Gibbons RD
    Schizophr Bull; 2021 Apr; 47(3):644-652. PubMed ID: 33164091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing anomalous perceptual experiences in nonpsychiatric individuals and outpatients with psychosis in Taiwan: an investigation using the cardiff anomalous perceptions scale (CAPS).
    Kao YC; Wang TS; Lu CW; Liu YP
    Psychiatr Q; 2013 Jun; 84(2):137-57. PubMed ID: 22878835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Audio-Visual Abnormalities Questionnaire (AVAQ): Development and validation of a new instrument for assessing anomalies in sensory perception in schizophrenia spectrum disorders.
    Nikitova N; Keane BP; Demmin D; Silverstein SM; Uhlhaas PJ
    Schizophr Res; 2019 Jul; 209():227-233. PubMed ID: 31182320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.
    Carrión RE; Auther AM; McLaughlin D; Olsen R; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cornblatt BA
    Schizophr Bull; 2019 Jun; 45(4):763-772. PubMed ID: 30351423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does hallucination perceptual modality impact psychosis risk?
    Niles HF; Walsh BC; Woods SW; Powers AR
    Acta Psychiatr Scand; 2019 Oct; 140(4):360-370. PubMed ID: 31355420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and structural correlates of abnormal involuntary movements in psychosis risk and first episode psychosis.
    Kindler J; Michel C; Schultze-Lutter F; Felber G; Hauf M; Schimmelmann BG; Kaess M; Hubl D; Walther S
    Schizophr Res; 2019 Oct; 212():196-203. PubMed ID: 31405623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial development and preliminary psychometric properties of the Prodromal Inventory of Negative Symptoms (PINS).
    Pelletier-Baldelli A; Strauss GP; Visser KH; Mittal VA
    Schizophr Res; 2017 Nov; 189():43-49. PubMed ID: 28189529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary psychometric properties of the brief Negative Symptom Scale in youth at Clinical High-Risk for psychosis.
    Strauss GP; Chapman HC
    Schizophr Res; 2018 Mar; 193():435-437. PubMed ID: 28779853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported cognitive distortions in the psychosis continuum: A Polish 18-item version of the Davos Assessment of Cognitive Biases Scale (DACOBS-18).
    Gawęda Ł; Prochwicz K; Krężołek M; Kłosowska J; Staszkiewicz M; Moritz S
    Schizophr Res; 2018 Feb; 192():317-326. PubMed ID: 28601498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of thought disorder predicts psychosis in persons at clinical high-risk.
    Perkins DO; Jeffries CD; Cornblatt BA; Woods SW; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Heinssen R; Mathalon DH; Seidman LJ; Tsuang MT; Walker EF; McGlashan TH
    Schizophr Res; 2015 Dec; 169(1-3):169-177. PubMed ID: 26441004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting psychosis risk using a specific measure of cognitive control: a 12-month longitudinal study.
    Guo JY; Niendam TA; Auther AM; Carrión RE; Cornblatt BA; Ragland JD; Adelsheim S; Calkins R; Sale TG; Taylor SF; McFarlane WR; Carter CS
    Psychol Med; 2020 Oct; 50(13):2230-2239. PubMed ID: 31507256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Handwriting analysis indicates spontaneous dyskinesias in neuroleptic naïve adolescents at high risk for psychosis.
    Dean DJ; Teulings HL; Caligiuri M; Mittal VA
    J Vis Exp; 2013 Nov; (81):e50852. PubMed ID: 24300590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis.
    Addington J; Shah H; Liu L; Addington D
    Schizophr Res; 2014 Mar; 153(1-3):64-7. PubMed ID: 24439270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.